Justice Department starts federal registrations for more than 900 medical marijuana dispensaries
The Trump administration began granting federal approval to more than 900 medical marijuana dispensaries across several states, the Department of Justice announced on October 30, 2026. The DEA is proceeding with registrations.
AI-assisted synthesis · Based on 4 outlets' reporting · Article text read from 2 of 4 outletsHow it's made
View timeline · 8 entriesWhat happened
Key facts
- The Trump administration began granting federal approval to more than 900 medical marijuana dispensaries.
- The dispensaries are located across several states.
- The Department of Justice announced the approvals on October 30, 2026.
- The Drug Enforcement Administration is moving forward with issuing registrations.
The brief
The Trump administration has begun granting federal approval to more than 900 medical marijuana dispensaries across several states, the Department of Justice announced. The DEA is proceeding with registrations, marking an initial phase in the federal process to reschedule cannabis.
The registrations are being issued to dispensaries in Alabama, Florida, Mississippi, South Dakota, Texas, Virginia, and West Virginia, according to the Washington Examiner. Marijuana Moment likewise reported that the administration had issued registrations to hundreds of dispensaries in states across the country.
The Department of Justice said the registrations mark the first phase of implementing rescheduling. The application pool is broader than dispensaries alone. The DEA said nearly 7,000 medical marijuana businesses had applied for federal protections; the Washington Examiner specifies that the applicants include state-licensed dispensaries, distributors, and manufacturers.
The figures describe applications, not completed registrations: the federal approvals announced so far cover more than 900 dispensaries. The Department of Justice cautioned that state licensure does not by itself provide federal registration.
It said registered dispensaries will face federal requirements for handling controlled substances, including security, inventory controls, and recordkeeping. Those rules establish conditions businesses must meet alongside the state licences under which they operate.
Attorney General Todd Blanche framed the policy in terms of medical access, saying, “The American people deserve access to the best medical treatments in the world.” The Department of Justice also said federal authorities would continue prosecuting illegal marijuana trafficking and related criminal activity under federal law.
The statements set out the administration’s two stated positions: advancing the registration process while maintaining enforcement against activity it considers illegal.
The Washington Examiner reports that the order set an initial 60-day period for dispensaries to satisfy applicable federal requirements, including completing the DEA’s pre-registration investigation, before receiving federal registration.
The DEA’s announced move to issue registrations and the application total indicate the scale of the process; the available account does not say how many of the nearly 7,000 applicants will ultimately receive registration. The immediate next step is the DEA’s review and issuance of registrations under the process.
Businesses seeking federal status will need to meet the applicable requirements, while the Department of Justice says it will continue pursuing illegal trafficking under federal law.
Why it matters
- More than 900 dispensaries are in the first announced group receiving federal approval, while nearly 7,000 medical marijuana businesses have applied; the gap makes the DEA’s registration decisions consequential for applicants.
- State-licensed dispensaries, distributors, and manufacturers seeking federal protections must distinguish state licensure from federal registration; the Department of Justice says state licences alone do not confer federal status.
- Registered dispensaries face federal handling requirements, including security, inventory controls, and recordkeeping, creating specific compliance obligations for businesses entering the process.
- The administration has stated both a medical-access rationale, in Attorney General Todd Blanche’s words, and an intention to continue prosecuting illegal marijuana trafficking and related criminal activity.
What to watch next
- Whether the DEA issues further federal registrations beyond the more than 900 dispensaries announced so far.
- How the DEA processes applications from the nearly 7,000 medical marijuana businesses that have applied.
- Whether applicants complete the DEA pre-registration investigation and other applicable requirements during the initial 60-day period described by the Washington Examiner.
- How the Department of Justice applies its stated commitment to prosecute illegal marijuana trafficking and related criminal activity as registrations proceed.
How it's being covered
Coverage analysisShow details4 source articles · 4 unique outletsOutlet political mix: Mostly Center· 2 Center · 1 Right · 1 unratedWhere the outlets are based: Unknown 50% · US/Canada 25% · Other 25%
How outlets' accounts compare
1 framing difference · 2 uncorroborated claims · 1 information gap- The Washington Examiner leads with approval for more than 900 dispensaries and identifies seven states where the DEA is issuing registrations; Marijuana Moment emphasizes the wider rescheduling process and the nearly 7,000 applications.
- Attorney General Todd Blanche said, “The American people deserve access to the best medical treatments in the world.”
- The Department of Justice said the registrations mark the first phase of implementing marijuana rescheduling.
- The sources do not establish how many of the nearly 7,000 applicants will receive federal registration.
Timeline
Developments from this story's sources, dated background we compiled and fact-checked, and our earlier coverage. Each row says which.- President Richard Nixon signed the Controlled Substances Act into law, establishing federal controls on controlled drugs.Background · compiled and fact-checked by Updat3
- California voters approved Proposition 215 on November 5, 1996, allowing medical marijuana under state law and beginning a state-level system that later spread to other states.Background · from our historical context
- Deputy Attorney General James Cole issued a Justice Department memorandum outlining federal enforcement priorities in states that had legalized marijuana.Background · compiled and fact-checked by Updat3
- On October 6, 2022, President Joe Biden directed the attorney general and the secretary of health and human services to review marijuana’s federal scheduling.Background · from our historical context
- HHS delivered its Schedule III recommendation to the DEA in August 2023.Background · from our historical context
- The Department of Health and Human Services recommended moving marijuana from Schedule I to Schedule III.Background · compiled and fact-checked by Updat3
- The DEA announced an administrative hearing on the proposed rescheduling, scheduled to begin December 2.Background · compiled and fact-checked by Updat3
- The Justice Department published a proposed rule to move marijuana from Schedule I to Schedule III.Background · compiled and fact-checked by Updat3
How we got here
On August 29, 2023, the Department of Health and Human Services recommended moving marijuana from Schedule I to Schedule III under the Controlled Substances Act; on May 16, 2024, the Justice Department published a proposed rule to make that change.
The Act also established federal controls on the manufacture, distribution, and dispensing of controlled substances, administered principally by the Drug Enforcement Administration. California voters approved Proposition 215 on November 5, 1996, allowing medical marijuana under state law and beginning a state-level system that later spread to other states.
Original sources
1 of 4 articles · Global · Show allEvery story links to the reporting it was built from. How we choose sources
Spotted a factual error, a broken link or a misleading summary? Tell us.